|
Crédit Agricole Private Equity
Crédit Agricole Private Equity, an AMF-authorized investment management company and wholly-owned subsidiary of Crédit Agricole S.A., specializes in direct private equity investment in unlisted companies. A multi-specialist, Crédit Agricole Private Equity has 50 investment teams focusing on different segments of the private equity market (LBO & Expansion, Venture Capital, Mezzanine, Renewable Energy, PPP Infrastructure, Special Situations, Co-Investment) and manages a total of €2.8 billion in various types of private equity vehicle (FCPR, SICAR, FCPI and SCR). Crédit Agricole Private Equity supports entrepreneurs in their expansion plans.
www.ca-privateequity.com
Innoven Partenaires
Innoven Partenaires is an independent venture capital firm, founded in 1997, with more than €200 million under management. Innoven Partenaires invests in France and across Europe in young companies with high growth potential in the life sciences, information technology, communications and energy / cleantech sectors. The investment team has a pro-active approach, working closely with portfolio companies, making available a broad international network, in-depth mergers and acquisitions and business development experience and a strong track record in bringing companies to IPO.
www.innoven-partenaires.com
|
 |
A Plus Finance
A Plus Finance is an independent venture capital firm based in Paris. A Plus Finance invests in all innovative fields with a focus on information technology. Its team mixes entrepreneurs and finance professionals, thus bringing the managers an understanding of what good execution means and what a long term vision of exit strategies implies. Managing €220 million, A Plus Finance invests from €1 to €5 million on a first round of financing.
www.aplusfinance.com
Delta Partners
Delta Partners is among the most active early-stage venture capital investors in Europe. Established in 1994 and with €230 million under management in 60 companies, the firm focuses on investing in early-stage technology companies across ICT and Healthcare, primarily Medical Technology. Current investments include Miracor Medical Systems GmbH, Genable Technologies Ltd., Glysure Ltd., Neoss Ltd., Heartscape Technologies Inc., and Advanced Surgical Concepts Ltd. The partners’ backgrounds in start-ups, operations, strategy and finance complement the drive and ambition of entrepreneurial management teams.
www.delta.ie
|
Overview
©